← Open Payments lookup

MARC RAAD: Open Payments

NPI 1316085665 · WOLCOTT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,325 in 146 payments from 34 companies in 2025. Trend: 2023 $3,230 · 2024 $4,270 · 2025 $3,325

Food & beverage: $3,325
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$380
Vanda Pharmaceuticals Inc.14$378
Ardelyx, Inc.14$297
Lilly USA, LLC10$243
Novo Nordisk Inc11$207
Otsuka America Pharmaceutical, Inc.8$193
Bayer Healthcare Pharmaceuticals Inc.7$167
Sumitomo Pharma America, Inc.8$147
ABBVIE INC.12$138
Boehringer Ingelheim Pharmaceuticals, Inc.6$131

Products named: IBSRELA, FANAPT, JARDIANCE, REXULTI, Kerendia, LOKELMA, Ozempic, HETLIOZ.

Industry payments across CT — which companies pay providers there.